Indication

Hypodermoclysis

Hypodermoclysis is a clinical procedure involving the infusion of fluids and medications directly into the subcutaneous space, rather than an intrinsic disease or pathological condition. Read more about Hypodermoclysis

7 drugs 7 manufacturers

Advertisement

Drugs that treat it

Common Hypodermoclysis therapies.

Showing 1–7 of 7 drugs

AMPHADASE (hyaluronidase)

HYALURONIDASE ENZYMES·ADJUNCT TREATMENT TO INCREASE ABSORPTION AND DISPERSION OF OTHER INJECTED DRUGS·+2
Amphastar Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Hypodermoclysis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hypodermoclysis.

Hypodermoclysis is a clinical procedure involving the infusion of fluids and medications directly into the subcutaneous space, rather than an intrinsic disease or pathological condition.

It is primarily indicated for managing mild-to-moderate dehydration, hypovolemia, or maintenance fluid requirements when oral fluid intake is inadequate and intravenous access is difficult or impractical.

This technique is most frequently utilized in frail geriatric populations, long-term care residents, and palliative or hospice care patients.

Physiologically, the administered fluids disperse through the loose subcutaneous connective tissue and are gradually absorbed into the systemic microcirculation via capillary and lymphatic diffusion.

Personalize your experience

Follow Hypodermoclysis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it